Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

BACKGROUND: Pharmacological inhibitors of vascular endothelial growth factor (VEGF) receptors, like vatalanib, have been tested in randomised trials (CONFIRM (Colorectal Oral Novel therapy For the Inhibition of Angiogenesis and Retarding of Metastases) 1 and 2) in colorectal cancer showing activity...

Full description

Saved in:
Bibliographic Details
Main Authors: Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Gatter, K C, Trarbach, T, Folprecht, G, Shi, M M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A L
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2012
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461163/
https://ncbi.nlm.nih.gov/pubmed/22910317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.369
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items